Preliminary Proxy Statement (Form PRE 14A)
-5d
Amendment to Current Report (Form 8-K/A)
4/16
ABVC BioPharma Announces 2024 Financial Results (Form 8-K)
4/15
Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
4/15
Late Filing Notice (Form NT 10-K)
3/31
Management Change/Compensation (Form 8-K)
3/7
Amendment to Current Report (Form 8-K/A)
1/13
1/6
Supplemental Prospectus - Form 424B4
-5m
Supplemental Prospectus - Form 424B4
-5m